Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 4, 2006, Pages 651-660

  Harbord, M W N ^a,b   Marks, D J B ^a   Forbes, A ^a   Bloom, S L ^a   Day, R M ^a   Segal, A W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHARIDIN; CASPASE; CHEMOATTRACTANT; CHEMOKINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BLISTER; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; FEMALE; GENOTYPE; HUMAN; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADULT; AGED; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CROHN DISEASE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS;

EID: 33746469061     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03016.x     Document Type: Article

References (50)

1. Satsangi J, Morecroft J, Shah NB, Nimmo E. Genetics of inflammatory bowel disease: scientific and clinical implications. Best Pract Res Clin Gastroenterol 2003; 17: 3-18.
2. Ekbom A, Montgomery SM. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract Res Clin Gastroenterol 2004; 18: 497-508.
3. Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 2000; 45: 1121-9.
4. Segal AW, Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet 1976; 2: 219-21.
5. Worsaae N, Staehr JK, Christensen KC. Impaired in vitro function of neutrophils in Crohn's disease. Scand J Gastroenterol 1982; 17: 91-6.
6. Wandall JH, Binder V. Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro. Gut 1982; 23: 173-80.
7. Marks DJ, Harbord MW, MacAllister R, et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006; 367: 668-78.
8. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005; 23: 197-223.
9. Matsumoto T, Nakamura S, Jin-No Y, et al. Role of granuloma in the immunopathogenesis of Crohn's disease. Digestion 2001; 63 (Suppl. 1): 43-7.
10. Morain CO, Segal AA, Walker D, Levi AJ. Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut 1981; 22: 817-22.
11. Wandall JH. Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis. Scand J Gastroenterol 1985; 20: 1151-6.
12. Rhodes JM, Potter BJ, Brown DJ, Jewell DP. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology 1982; 82: 1327-34.
13. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003; 199: 28-35.
14. Nemunaitis J. A comparative review of colony-stimulating factors. Drugs 1997; 54: 709-29.
15. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ. Sargramostim for active Crohn's disease. N Engl J Med 2005; 352: 2193-201.
16. Korzenik JR, Dieckgraefe BK. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment Pharmacol Ther 2005; 21: 391-400.
17. Day RM, Harbord M, Forbes A, Segal AW. Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans. J Immunol Methods 2001; 257: 213-20.
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1984; 24: 2-6.
19. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 110: 353-6.
20. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 1: 514.
21. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
22. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6.
23. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925-8.
24. Fleit HB, Wright SD, Unkeless JC. Human neutrophil Fc gamma receptor distribution and structure. Proc Natl Acad Sci USA 1982; 79: 3275-9.
25. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-3.
26. Segal AW, Jones OT. Absence of cytochrome b reduction in stimulated neutrophils from both female and male patients with chronic granulomatous disease. FEBS Lett 1980; 110: 111-4.
27. Harvath L, Falk W, Leonard EJ. Rapid quantitation of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J Immunol Methods 1980; 37: 39-45.
28. Ichinose Y, Hara N, Ohta M, et al. Recombinant granulocyte colony-stimulating factor and lipopolysaccharide maintain the phenotype of and superoxide anion generation by neutrophils. Infect Immun 1990; 58: 1647-52.
29. Brunner M, Schmiedberger A, Schmid R, et al. Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling. Br J Clin Pharmacol 1998; 46: 425-31.
30. Philippidis P, Mason JC, Evans BJ, et al. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004; 94: 119-26.
31. Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO. Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2004; 50: 2273-80.
32. Evans BJ, McDowall A, Taylor PC, Hogg N, Haskard DO, Landis RC. Shedding of lymphocyte function-associated antigen (LFA)-1 in a human inflammatory response. Blood 2006; 107: 3593-9.
33. Gouwy M, Struyf S, Proost P, Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005; 16: 561-80.
34. Zen K, Parkos CA. Leukocyte-epithelial interactions. Curr Opin Cell Biol 2003; 15: 557-64.
35. Li J, Moran T, Swanson E, et al. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 2004; 13: 1715-25.
36. van Heel DA, Ghosh S, Butler M, et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 2005; 365: 1794-6.
37. Gijsbers K, Van Assche G, Joossens S, et al. CXCR1-binding chemokines in inflammatory bowel diseases: downregulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. Eur J Immunol 2004; 34: 1992-2000.
38. Brandt E, Colombel JF, Ectors N, et al. Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD). Clin Exp Immunol 2000; 122: 180-5.
39. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996; 88: 335-40.
40. Decleva E, Cramer R, Zabucchi G. Glycosylation improves the priming effect exerted by recombinant human granulocyte colony-stimulating factor (lenograstim) on human neutrophil superoxide production. Int J Tissue React 1995; 17: 191-8.
41. Harper PH, Lee EC, Kettlewell MG, Bennett MK, Jewell DP. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985; 26: 279-84.
42. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338: 771-4.
43. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.
44. Thrasher AJ, Keep NH, Wientjes F, Segal AW. Chronic granulomatous disease. Biochim Biophys Acta 1994; 1227: 1-24.
45. Dieckgraefe BK, Korzenik JR, Husain A, Dieruf L. Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr 2002; 161 (Suppl. 1): S88-92.
46. D'Agata ID, Paradis K, Chad Z, Bonny Y, Seidman E. Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 1996; 39: 605-8.
47. Ishii E, Matui T, Iida M, Inamitu T, Ueda K. Chediak-Higashi syndrome with intestinal complication. Report of a case. J Clin Gastroenterol 1987; 9: 556-8.
48. Stevens C, Peppercorn MA, Grand RJ. Crohn's disease associated with autoimmune neutropenia. J Clin Gastroenterol 1991; 13: 328-30.
49. Lamport RD, Katz S, Eskreis D. Crohn's disease associated with cyclic neutropenia. Am J Gastroenterol 1992; 87: 1638-42.
50. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 2005; 102: 18129-34.